Table 3 Comparison of surgical outcomes of 420 patients with placenta previa and accreta
Indicators | Balloon Group | Control Group | P | t/z/x2 |
|---|---|---|---|---|
(n = 248) | (n = 172) | |||
EBL (ml) | 2200 (500–12,000) | 2150 (500–15,000) | 0.897 | −0.13 |
PRBCs transfusion (U) | 3 (0–31.5) | 3 (0–39) | 0.042 | −2.037 |
PRBCs > 4 units transfused | 73/248 | 65/172 | 0.073 | 3.214 |
PRBCs > 8 units transfused | 28/248 | 40/172 | 0.001 | 10.716 |
FFP transfusion (U) | 0 (0–2250) | 0 (0–2800) | 0.171 | −1.37 |
PLT transfusion (U) | 0 (0–1) | 0 (0–1) | 0.035 | −2.104 |
Autologous blood transfusion (ml) | 220 (0–2700) | 217 (0–2144) | 0.527 | −0.633 |
Operative fluids transfusion (ml) | 4000 (1000–15,600) | 3700 (1700–17,700) | 0.137 | −1.487 |
Blood loss within postoperative 24 h (ml) | 35 (0–2210) | 40 (0–1908) | 0.555 | −0.590 |
Postoperative length of stay (d) | 5 (2–17) | 5 (2–16) | 0.497 | −0.68 |
Maternal ICU admission of days (d) | 2 (1–5) | 2 (1–6) | 0.310 | −1.015 |
Total hospitalization costs (CYN) | 45,624.4 ± 11,061.9 | 37,523.1 ± 14,662.2 | 0.000 | −6.074 |
Surgery costs (CYN) | 19,910.6 ± 2622.6 | 11,850.5 ± 3146.1 | 0.000 | −27.328 |
Maternal ICU admission rate (n%) | 42/248 (16.94%) | 47/172 (27.33%) | 0.010 | 6.565 |
Postoperative pyrexia (≥38.5 °C) n% | 24/248 (9.68%) | 10/172 (5.81%) | 0.153 | 2.038 |
Postoperative anemia (HGB < 100 g/L), n% | 158/248 (63.71%) | 103/172 (59.88%) | 0.427 | 0.632 |
Cesarean hysterectomy (n%) | 90/248 (36.3%) | 61/172 (35.5%) | 0.862 | 0.03 |
Bladder injury (%) | 8/248 (3.23%) | 5/172 (2.91%) | 0.853 | 0.034 |
Ureter injury | 6/248 (2.42%) | 3/172 (1.74%) | 0.638 | 0.221 |
Vesico vaginal fistula | 0/248 | 0/172 | / | / |